News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Menzaghi Frederique Ph.D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/07/2023 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 6,802 shares
@ $9.71, valued at
$66k
|
|
| 04/05/2022 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 1,784 shares
@ $11.91, valued at
$21.2k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2021 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 12,607 shares
@ $0 |
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,812 shares
@ $15.3, valued at
$43k
|
|
| 12/29/2020 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 8,000 shares
@ $0 |
|
| 04/21/2020 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 37,500 shares
@ $0
Sold 12,894 shares
@ $15.58, valued at
$200.9k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $18.7, valued at
$74.8k
|
|
| 10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $22.92, valued at
$458.4k
|
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 8,996 shares
@ $27.5, valued at
$247.4k
|
|
| 07/03/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $21.9, valued at
$438k
|
|
| 05/30/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 37,500 shares
@ $0
Sold 11,397 shares
@ $21.19, valued at
$241.5k
|
|
| 03/14/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,197 shares
@ $17.5, valued at
$55.9k
Sold 16,803 shares
@ $18.87, valued at
$317.1k
|
|
| 03/08/2019 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $16.1, valued at
$2.4M
|
|
| 03/04/2019 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $17.5, valued at
$26.3k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,300 shares
@ $12.53, valued at
$53.9k
|
|
| 12/31/2018 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 11,779 shares
@ $0 |
|
| 12/06/2018 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $18.36, valued at
$55.1k
|
|
| 11/05/2018 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $18.77, valued at
$56.3k
Exercised 40,000 options to buy
@ $2.05, valued at
$82k
|
|
| 11/05/2018 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.25, valued at
$22.5k
|
|
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2018 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $19.81, valued at
$59.4k
|
|
| 08/22/2018 |
4
| Menzaghi Frederique Ph.D. (Sr VP-Research & Development) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $18.89, valued at
$56.7k
|
|
|
|
|